OCULOPHARYNGEAL MUSCULAR DYSTROPHY Experts

We have collected the completed list of expert related to OCULOPHARYNGEAL MUSCULAR DYSTROPHY using public data available on different databases.

OCULOPHARYNGEAL MUSCULAR DYSTROPHY Experts map



If you find this map or researchers for OCULOPHARYNGEAL MUSCULAR DYSTROPHY useful, maybe you will be also interested in other rare diseases proffesionals like our leishmaniasis expert list ,or our malignant hyperthermia of anesthesia expert list

OCULOPHARYNGEAL MUSCULAR DYSTROPHY Experts list

Mr Martine SIMONELIG

 MONTPELLIER. FRANCE

  Investigator of research project - Coordinator of research network

  • Research area/topic:
    riboOPMD: Ribosomal and small non-coding RNAs in oculopharyngeal muscular dystrophy - FR
  • IGH - UMR 9002 - CNRS - Université de Montpellier, Institut de Génétique Humaine (IGH)
  • martine.*********@***.cnrs.fr
Complete Info

Dr Capucine TROLLET

 PARIS. FRANCE

  Investigator of research project

  • Research area/topic:
    Long and small non coding RNA in oculopharyngeal muscular dystrophy
  • Centre de recherche en Myologie, Institut de Myologie - Hôpital Pitié-Salpêtrière
  • capucine********@***c.fr
Complete Info

Dr J.A.H. [Just] EEKHOF

 LEIDEN. NETHERLANDS

  Investigator of research project

  • Research area/topic:
    GMA - Group medical appointments for neuromuscular patients: To compare group medical appointments (shared medical appointments or group visits) with conventional one to one appointments for patients with a chronic neuromuscular disease in terms of health outcome (quality of life) and costs, an intervention study.
  • LUMC - Leids Universitair Medisch Centrum
  • j.a.h.******@***c.nl
Complete Info

Ms F. [Femke] SEESING

 UTRECHT. NETHERLANDS

  Investigator of research project

  • Research area/topic:
    GMA - Group medical appointments for neuromuscular patients: To compare group medical appointments (shared medical appointments or group visits) with conventional one to one appointments for patients with a chronic neuromuscular disease in terms of health outcome (quality of life) and costs, an intervention study.
  • Piet van Dommelenhuis
  • f.se*****@***.nl
Complete Info

Other experts list that you may find interesting:

All the contact information provided is based on public data available in orpha.net.